Temocillin

DB12343ApprovedInvestigationalWithdrawnSmall molecule

Temocillin has been investigated in Infection, Liver Dysfunction, and Urinary Tract Infection.

Chemical structure of Temocillin
Mechanism
Curator reviewed
Formula / weight
C16H18N2O7S2 · 414.45 g/mol (avg)

Resolves to

Compound
UNII03QB156W6ICAS66148-78-5ChEMBLCHEMBL1276310ChEBI51817PubChem171758
Clinical / RWD
RxNorm37775ATCJ01CA17ATCJ01CR50
Structure
InChIKeyBVCKFLJARNKCSS-DWPRYXJFSA-NSMILESCO[C@]1(NC(=O)C(C(O)=O)C2=CSC=C2)[C@H]2SC(C)(C)[C@@H](N2C1=O)C(O)=O

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
194Drug interactionsStructured to mechanism, not free text
Sign in
11Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2ATC codesIncluding every combination product, plus 12 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which companies are running trials of Temocillin, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In